AstraZeneca Pharmaceuticals LP v. Secretary United States Department of Health and H, et al

  1. January 30, 2023

    HHS Can't Force 'Unlimited' Drug Discounts, 3rd Circ. Says

    Drugmakers don't have to sell their products at a discount through an unlimited number of retail pharmacies just because those pharmacies partnered with health care providers for low-income or uninsured patients under a federal program, the Third Circuit ruled Monday.

  2. November 15, 2022

    HHS, Drug Cos. Spar Over Pharmacy Limits In Discount Law

    The limited number of hospitals with in-house pharmacies serving underprivileged communities meant a federal drug discount program had to gradually expand to include retail pharmacies, and that program should bar drugmakers from restricting which pharmacies can order the discounted drugs, an attorney for the U.S. Department of Health and Human Services argued to a Third Circuit panel Tuesday.

  3. October 31, 2022

    Riding Circuit: November's Notable Appellate Arguments

    In the inaugural edition of Law360's monthly preview of appellate arguments worth watching, Law360 breaks down an epic antitrust case challenging Apple's limitations on its App Store, a 3-D printed gun fight that has seen Fifth Circuit judges complain about a lack of comity between circuits, and a power pricing faceoff that implicates the limits of bankruptcy court jurisdiction.

  4. August 11, 2022

    HHS Wants 3rd Circ. To Revive Drug Discount Violation Notice

    The U.S. Department of Health and Human Services on Thursday asked the Third Circuit to reinstate an enforcement letter to pharmaceutical giant AstraZeneca accusing it of going against a federal discount drug program, saying a federal judge wrongly concluded the letter went against the Administrative Procedure Act.